Bionomics (BNOX) Stock Price, News & Analysis
What Changed
Company Description
Bionomics (NASDAQ: BNOX) is classified in the research and development in biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $4.9M, ranking #6,959 among all listed U.S. companies by market cap.
BNOX has declined 80.7% over the past year. Shares last traded at $0.2531.
This page collects what Stock Titan holds for BNOX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bionomics (BNOX) stock last closed at $0.2531. Over the past 12 months, the stock has lost 80.7%. At a market capitalization of $4.9M, BNOX is classified as a micro-cap stock.
BNOX Rankings
Latest News
Bionomics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, conferences. View all BNOX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BNOX Company Profile & Sector Positioning
Bionomics (BNOX) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.